Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

VodafoneThree taps Ericsson and Nokia for UK expansion

(Sharecast News) - VodafoneThree has awarded a £2.0bn contract to Ericsson and Nokia to supply 5G communications equipment across the UK, marking a major step in the newly merged group's long-term network investment strategy. Ericsson, named as the lead vendor, said its share of the deal was worth SEK 12.5bn (£985.31m), while Nokia declined to disclose financial terms but noted the agreement marked its return as a supplier to Vodafone and Three in the UK. Nokia will provide radio access and core network equipment to approximately 7,000 sites nationwide. Ericsson will deploy AI-driven, energy-efficient hardware and smart antennas to boost data speeds in key cities, including London, Cardiff, Edinburgh and Belfast.

The contract follows the completion of Vodafone and CK Hutchison's UK merger in June, which created VodafoneThree and outlined plans to invest £11bn over the next decade to build one of Europe's most advanced 5G networks.

The deal will also provide a much-needed boost to both Nordic firms, which have faced pressure from slowing global demand and tariff-related headwinds in the US.

As of 0950 BST, Vodafone shares were down 0.54% at 84.94p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.